当前位置:首页 - 行情中心 - 金域医学(603882) - 财务分析 - 现金流量表

金域医学

(603882)

  

流通市值:134.96亿  总市值:135.87亿
流通股本:4.60亿   总股本:4.63亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金4,812,327,401.643,066,685,526.721,436,169,512.277,555,453,022.14
  收到的税费返还80,133,379.0578,832,793.921,110,467.78721,980.93
  收到其他与经营活动有关的现金81,225,288.3568,235,534.5239,847,254.38109,699,462.24
  经营活动现金流入小计4,973,686,069.043,213,753,855.161,477,127,234.437,665,874,465.31
  购买商品、接受劳务支付的现金2,177,622,945.441,393,331,272.69681,236,082.143,837,467,210.19
  支付给职工以及为职工支付的现金1,243,528,966.87859,311,400.07452,272,363.431,900,111,957.87
  支付的各项税费133,915,275.8110,819,907.0642,057,574.7183,388,043.09
  支付其他与经营活动有关的现金746,710,986.45499,821,783.89247,056,522.01838,559,732.58
  经营活动现金流出小计4,301,778,174.562,863,284,363.711,422,622,542.286,759,526,943.73
  经营活动产生的现金流量净额671,907,894.48350,469,491.4554,504,692.15906,347,521.58
二、投资活动产生的现金流量:
  收回投资收到的现金60,786,632.3210,335,197.437,073,522.610
  取得投资收益收到的现金7,473,000.811,725,775.881,383,598.951,509,860.64
  处置固定资产、无形资产和其他长期资产收回的现金净额1,638,438.91,181,768.55590,262.7515,202,038.68
  处置子公司及其他营业单位收到的现金净额---0
  投资活动现金流入小计69,898,072.0313,242,741.869,047,384.3116,711,899.32
  购建固定资产、无形资产和其他长期资产支付的现金291,845,110.9174,236,937.49106,474,281.8446,361,442.37
  投资支付的现金40,833,333.3438,333,333.34-25,879,130.36
  取得子公司及其他营业单位支付的现金---0
  支付其他与投资活动有关的现金---0
  投资活动现金流出小计332,678,444.24212,570,270.83106,474,281.8472,240,572.73
  投资活动产生的现金流量净额-262,780,372.21-199,327,528.97-97,426,897.49-455,528,673.41
三、筹资活动产生的现金流量:
  取得借款收到的现金113,745,121.5583,745,121.5527,458,021.55368,838,299.27
  筹资活动现金流入小计113,745,121.5583,745,121.5527,458,021.55368,838,299.27
  偿还债务支付的现金36,422,513.8929,997,513.896,425,57098,621,943.89
  分配股利、利润或偿付利息支付的现金432,424,230.77426,807,753.62410,074,307.13427,880,350.28
  其中:子公司支付给少数股东的股利、利润14,200,00014,200,000-8,314,928.69
  支付其他与筹资活动有关的现金38,636,026.0828,298,735.9213,132,392.11331,136,524.73
  筹资活动现金流出小计507,482,770.74485,104,003.43429,632,269.24857,638,818.9
  筹资活动产生的现金流量净额-393,737,649.19-401,358,881.88-402,174,247.69-488,800,519.63
四、汇率变动对现金及现金等价物的影响-6,458,287.49-7,028,422.73-1,510,271.7110,832,079.85
五、现金及现金等价物净增加额8,931,585.59-257,245,342.13-446,606,724.74-27,149,591.61
  加:期初现金及现金等价物余额2,422,524,549.622,422,524,549.622,422,524,549.622,449,674,141.23
  期末现金及现金等价物余额2,431,456,135.212,165,279,207.491,975,917,824.882,422,524,549.62
补充资料:
  净利润--96,868,140.52--414,703,700.92
  资产减值准备--125,413.97-72,623,272.86
  固定资产和投资性房地产折旧-160,961,885.9-434,946,280.78
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-160,961,885.9-434,946,280.78
  无形资产摊销-6,408,546.82-10,264,811.97
  长期待摊费用摊销-44,551,120.84-98,396,472.41
  处置固定资产、无形资产和其他长期资产的损失--2,441,961.14--6,364,363.75
  固定资产报废损失-439,518.91-149,958,864.97
  公允价值变动损失---30,798,817.27
  财务费用-8,006,679.54-18,223,688.51
  投资损失--2,008,308.27-37,083,018.3
  递延所得税--48,843,708.63--119,864,087.04
  其中:递延所得税资产减少--45,647,654.21--90,314,044.91
    递延所得税负债增加--3,196,054.42--29,550,042.13
  存货的减少-7,591,803.02-49,892,124.76
  经营性应收项目的减少-78,365,080.54-263,523,149.7
  经营性应付项目的增加--151,710,293.42--413,541,664.33
  其他-28,298,735.92--33,186,128.1
  现金的期末余额-2,165,279,207.49-2,422,524,549.62
  减:现金的期初余额-2,422,524,549.62-2,449,674,141.23
  现金及现金等价物的净增加额--257,245,342.13--27,149,591.61
公告日期2025-10-302025-08-232025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑